Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-β

EMBO Journal

Volumn 19, Issue 19, 2000, Pages 5178-5193

  Feng, Xin Hua ^a,b   Lin, Xia ^b   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cdk inhibitor p15(Ink4B); Smad; Sp1; TGF ; Transcription

Indexed keywords

NUCLEOPROTEIN; PROTEIN P15; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; DNA BINDING; GENE INDUCTION; GROWTH DISORDER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034596993     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.19.5178     Document Type: Article

References (89)

1. 467 is required for Smad2-Smad4 complex formation and signaling
2. The biological role of transforming growth factor-β in cancer development
3. Mads and Smads in TGFβ signalling
4. Characterization of the promoter region of the human transforming growth factor-β type II receptor gene
5. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma
6. Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: Regulation by TGF-β
7. The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development
8. A transcriptional partner for MAD proteins in TGF-β signaling
9. Smad4 and FAST-1 in the assembly of activin-responsive factor
10. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif
11. The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling
12. Drosophila dSmad2 and Atr-I transmit activin/TGFβ signals
13. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
14. The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B
15. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
16. TGF-β receptor signaling
17. Smads: Transcriptional activators of TGF-β responses
18. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
19. Ligand-independent activation of TGF-β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors
20. Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors
21. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation
22. Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Sp1
23. Multiple specific contacts between a mammalian transcription factor and its cognate promoters
24. Human transforming growth factor-β 3: Recombinant expression, purification and biological activities in comparison with transforming growth factors-β1 and -β2
25. Sp1 is required for the early response of α2(I) collagen to transforming growth factor-β1
26. Homozygous deletion map at 18q21.1 in pancreatic cancer
27. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
28. p15(ink4B) Is a potential effector of TGF-β-induced cell cycle arrest
29. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
30. TGF-β signalling from cell membrane to nucleus through SMAD proteins
31. Molecular mechanisms of transforming growth factor-β signaling
32. Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene
33. The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4
34. Structure and expression of the promoter for the human type II transforming growth factor-β receptor
35. Interplay of signal mediators of decapentaplegic (Dpp): Molecular characterization of mothers against dpp, Medea and daughters against dpp
36. TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300
37. Cloning, characterization and expression of the transforming growth factor-β type I receptor promoter in fetal rat bone cells
38. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin and bone morphogenetic protein-inducible enhancer
39. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors
40. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Dpp
41. Characterization of the promoter region of the human transforming growth factor-β1 gene
42. Transcriptional activation of transforming growth factor β1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1
43. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2
44. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
45. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction
46. Potential role of WAF1/Cip1/ p21 as a mediator of TGF-β cytoinhibitory effect
47. Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15(INK4B) through an Sp1 consensus site
48. FAST-2 is a mammalian winged-helix protein which mediates TGF-β signals
49. A human Mad protein acting as a BMP-regulated transcriptional activator
50. Dual role of the Smad4/ DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes
51. MADR-2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling
52. TGF-β signal transduction
53. Regulation of the human p21/ WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
54. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4
55. Role of p300, a transcriptional coactivator, in signalling of TGF-β
56. Molecular cloning and structure of the human transforming growth factor-β2 gene promoter
57. Physical and functional interaction of SMADs and p300/CBP
58. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
59. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
60. Transforming growth factor-β-mediated p15Ink4B induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
61. Frequency of Smad gene mutations in human cancers
62. Molecular and cell biology of TGF-β
63. Purification of transcription cofactor complex CRSP
64. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1
65. DPC4 gene in various tumor types
66. TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein
67. 1-phase progression
68. A structural basis for mutational inactivation of the tumour suppressor Smad4
69. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signaling
70. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter
71. 467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling
72. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced Smad-dependent transcriptional activation
73. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells
74. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells
75. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor-β
76. Transforming growth factor-βs in mammary tumorigenesis: Promoters or antipromoters?
77. Myc downregulation by transforming growth factor β required for activation of the p15(Ink4b) G(1) arrest pathway
78. Tumor suppressing pathways
79. Smads and early developmental signaling by the TGFβ superfamily
80. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses
81. Mechanism of activation of the TGF-β receptor
82. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
83. Human Smad3 and Smad4 are sequence-specific transcription activators
84. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
85. The tumor suppressor Smad 4/ DPC 4 as a central mediator of Smad function: Cooperativity with other Smads and interference of a Smad 4/DPC 4 mutant with nuclear translocation of Smads
86. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription
87. Characterization of human FAST-1, a TGFβ and activin signal transducer
88. Smad3 mutant mice develop metastatic colorectal cancer